Los Angeles Capital Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Los Angeles Capital Management’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40,635	Closed	-$2.66M	–	1262
2023 Q3	$2.66M	Buy	40,635 +33,328	+456%	+$2.1M	0.01%	392
2023 Q2	$425K	Buy	7,307 +1,344	+23%	+$84.8K	﹤0.01%	907
2023 Q1	$368K	Sell	5,963 -585	-9%	-$35.1K	﹤0.01%	952
2022 Q4	$416K	Sell	6,548 -734	-10%	-$53.2K	﹤0.01%	941
2022 Q3	$529K	Sell	7,282 -7,787	-52%	-$580K	﹤0.01%	909
2022 Q2	$1.02M	Sell	15,069 -11	-0.1%	-$791	0.01%	712
2022 Q1	$1.37M	Sell	15,080 -205	-1%	-$16.8K	0.01%	651
2021 Q4	$1.4M	Sell	15,285 -11,772	-44%	-$1.01M	0.01%	616
2021 Q3	$2.19M	Buy	27,057 +240	+0.9%	+$20.2K	0.01%	511
2021 Q2	$2.5M	Buy	26,817 +14,199	+113%	+$1.38M	0.01%	537
2021 Q1	$1.35M	Buy	+12,618	New	+$1.31M	0.01%	766

Other funds holding NARI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Los Angeles Capital Management's NARI Position: Q4 2023 in Review

Los Angeles Capital Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2023, closing a stake of 40,635 shares — an estimated $2.66M sold.

Los Angeles Capital Management first reported a position in NARI in Q1 2021 and held it in 11 quarters. The position peaked at $2.66M in Q3 2023. 252 funds tracked by Wall St. Rank hold NARI as of Q4 2023.

Los Angeles Capital Management reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Los Angeles Capital Management sold 40,635 Inari Medical, Inc. Common Stock shares in Q4 2023, an estimated $2.66M.
Los Angeles Capital Management first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
Los Angeles Capital Management's Inari Medical, Inc. Common Stock position peaked at $2.66M in Q3 2023.
252 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2023.

Based on Los Angeles Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.